This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Dynogen Pharmaceuticals (repositions CNS drugs as treatments for genitourinary and gastrointestinal diseases) will use its in vivo neuropharmacology platform to study several of Johnson & Johnson Pharmaceutical R&D's compounds to test their potential as therapies for overactive bladder.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?